nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—peripheral nervous system neoplasm	0.424	1	CbGaD
Sitagliptin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0681	0.173	CbGbCtD
Sitagliptin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0496	0.126	CbGbCtD
Sitagliptin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0496	0.126	CbGbCtD
Sitagliptin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0344	0.0874	CbGbCtD
Sitagliptin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0297	0.0755	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0287	0.0728	CbGbCtD
Sitagliptin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0276	0.0702	CbGbCtD
Sitagliptin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0212	0.0538	CbGbCtD
Sitagliptin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0197	0.0502	CbGbCtD
Sitagliptin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0194	0.0493	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0336	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0127	0.0322	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0116	0.0295	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00793	0.0201	CbGbCtD
Sitagliptin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000182	0.000997	CcSEcCtD
Sitagliptin—Rash—Topotecan—peripheral nervous system neoplasm	0.000182	0.000997	CcSEcCtD
Sitagliptin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000182	0.000996	CcSEcCtD
Sitagliptin—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000181	0.000995	CcSEcCtD
Sitagliptin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000993	CcSEcCtD
Sitagliptin—Cough—Etoposide—peripheral nervous system neoplasm	0.000181	0.000992	CcSEcCtD
Sitagliptin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000991	CcSEcCtD
Sitagliptin—Headache—Topotecan—peripheral nervous system neoplasm	0.000181	0.00099	CcSEcCtD
Sitagliptin—Rash—Tretinoin—peripheral nervous system neoplasm	0.00018	0.000989	CcSEcCtD
Sitagliptin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00018	0.000989	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00018	0.000989	CcSEcCtD
Sitagliptin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00018	0.000988	CcSEcCtD
Sitagliptin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00018	0.000988	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00018	0.000987	CcSEcCtD
Sitagliptin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000179	0.000984	CcSEcCtD
Sitagliptin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000983	CcSEcCtD
Sitagliptin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000179	0.000982	CcSEcCtD
Sitagliptin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000179	0.000982	CcSEcCtD
Sitagliptin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000179	0.000981	CcSEcCtD
Sitagliptin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.000979	CcSEcCtD
Sitagliptin—Pain—Vincristine—peripheral nervous system neoplasm	0.000179	0.000979	CcSEcCtD
Sitagliptin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000179	0.000979	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000979	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000979	CcSEcCtD
Sitagliptin—Rash—Melphalan—peripheral nervous system neoplasm	0.000178	0.000976	CcSEcCtD
Sitagliptin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000178	0.000975	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000972	CcSEcCtD
Sitagliptin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000966	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000966	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000963	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000175	0.000961	CcSEcCtD
Sitagliptin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000174	0.000956	CcSEcCtD
Sitagliptin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000956	CcSEcCtD
Sitagliptin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000946	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000945	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000172	0.000944	CcSEcCtD
Sitagliptin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000944	CcSEcCtD
Sitagliptin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000171	0.000939	CcSEcCtD
Sitagliptin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000171	0.000939	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000171	0.000936	CcSEcCtD
Sitagliptin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00017	0.000931	CcSEcCtD
Sitagliptin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00017	0.000931	CcSEcCtD
Sitagliptin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000169	0.000928	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000922	CcSEcCtD
Sitagliptin—Infection—Etoposide—peripheral nervous system neoplasm	0.000168	0.000921	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000168	0.000919	CcSEcCtD
Sitagliptin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000168	0.000919	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000917	CcSEcCtD
Sitagliptin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000914	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000165	0.000905	CcSEcCtD
Sitagliptin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000164	0.000901	CcSEcCtD
Sitagliptin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000896	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000894	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000894	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000885	CcSEcCtD
Sitagliptin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00016	0.00088	CcSEcCtD
Sitagliptin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000879	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00016	0.000877	CcSEcCtD
Sitagliptin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.000875	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000875	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000159	0.000874	CcSEcCtD
Sitagliptin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000866	CcSEcCtD
Sitagliptin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000853	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00085	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000846	CcSEcCtD
Sitagliptin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000154	0.000844	CcSEcCtD
Sitagliptin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000152	0.000834	CcSEcCtD
Sitagliptin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000832	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000829	CcSEcCtD
Sitagliptin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000825	CcSEcCtD
Sitagliptin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00015	0.000825	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00015	0.000822	CcSEcCtD
Sitagliptin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00082	CcSEcCtD
Sitagliptin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000815	CcSEcCtD
Sitagliptin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000815	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000149	0.000815	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000814	CcSEcCtD
Sitagliptin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000813	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000808	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000808	CcSEcCtD
Sitagliptin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000147	0.000806	CcSEcCtD
Sitagliptin—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000801	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000146	0.000801	CcSEcCtD
Sitagliptin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000146	0.0008	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000799	CcSEcCtD
Sitagliptin—Pain—Etoposide—peripheral nervous system neoplasm	0.000145	0.000793	CcSEcCtD
Sitagliptin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000145	0.000793	CcSEcCtD
Sitagliptin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000792	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000786	CcSEcCtD
Sitagliptin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000786	CcSEcCtD
Sitagliptin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000143	0.000783	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000771	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00077	CcSEcCtD
Sitagliptin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000765	CcSEcCtD
Sitagliptin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000139	0.000764	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000763	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000139	0.000761	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000759	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000138	0.000758	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000138	0.000757	CcSEcCtD
Sitagliptin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000756	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000754	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000754	CcSEcCtD
Sitagliptin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000749	CcSEcCtD
Sitagliptin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000749	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000748	CcSEcCtD
Sitagliptin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000136	0.000746	CcSEcCtD
Sitagliptin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000744	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000741	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000739	CcSEcCtD
Sitagliptin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000134	0.000737	CcSEcCtD
Sitagliptin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000134	0.000733	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000733	CcSEcCtD
Sitagliptin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000728	CcSEcCtD
Sitagliptin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000133	0.000728	CcSEcCtD
Sitagliptin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000726	CcSEcCtD
Sitagliptin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000726	CcSEcCtD
Sitagliptin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000723	CcSEcCtD
Sitagliptin—Rash—Vincristine—peripheral nervous system neoplasm	0.000132	0.000722	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000132	0.000721	CcSEcCtD
Sitagliptin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000721	CcSEcCtD
Sitagliptin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000719	CcSEcCtD
Sitagliptin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000717	CcSEcCtD
Sitagliptin—Headache—Vincristine—peripheral nervous system neoplasm	0.000131	0.000717	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000713	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000708	CcSEcCtD
Sitagliptin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000706	CcSEcCtD
Sitagliptin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000693	CcSEcCtD
Sitagliptin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000692	CcSEcCtD
Sitagliptin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000684	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000125	0.000683	CcSEcCtD
Sitagliptin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000124	0.00068	CcSEcCtD
Sitagliptin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000679	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000674	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000672	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000669	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000667	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000121	0.000665	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000665	CcSEcCtD
Sitagliptin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000664	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000664	CcSEcCtD
Sitagliptin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000661	CcSEcCtD
Sitagliptin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00066	CcSEcCtD
Sitagliptin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000117	0.000644	CcSEcCtD
Sitagliptin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000641	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00064	CcSEcCtD
Sitagliptin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000638	CcSEcCtD
Sitagliptin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000638	CcSEcCtD
Sitagliptin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000637	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000116	0.000635	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000633	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000628	CcSEcCtD
Sitagliptin—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000628	CcSEcCtD
Sitagliptin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000625	CcSEcCtD
Sitagliptin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000619	CcSEcCtD
Sitagliptin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000616	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000614	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000112	0.000613	CcSEcCtD
Sitagliptin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000612	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000612	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00061	CcSEcCtD
Sitagliptin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000601	CcSEcCtD
Sitagliptin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000109	0.0006	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000593	CcSEcCtD
Sitagliptin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000591	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000108	0.00059	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000589	CcSEcCtD
Sitagliptin—Rash—Etoposide—peripheral nervous system neoplasm	0.000107	0.000585	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000107	0.000584	CcSEcCtD
Sitagliptin—Headache—Etoposide—peripheral nervous system neoplasm	0.000106	0.000581	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000581	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000578	CcSEcCtD
Sitagliptin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000575	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000573	CcSEcCtD
Sitagliptin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000572	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00057	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000567	CcSEcCtD
Sitagliptin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000556	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000556	CcSEcCtD
Sitagliptin—Nausea—Etoposide—peripheral nervous system neoplasm	0.0001	0.000551	CcSEcCtD
Sitagliptin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00055	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.000547	CcSEcCtD
Sitagliptin—Myalgia—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000542	CcSEcCtD
Sitagliptin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.000542	CcSEcCtD
Sitagliptin—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.00054	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000539	CcSEcCtD
Sitagliptin—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000536	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000532	CcSEcCtD
Sitagliptin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.67e-05	0.00053	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.00053	CcSEcCtD
Sitagliptin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.48e-05	0.00052	CcSEcCtD
Sitagliptin—Infection—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000517	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000514	CcSEcCtD
Sitagliptin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.00051	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000509	CcSEcCtD
Sitagliptin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000505	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000502	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000502	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.0005	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.09e-05	0.000498	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000496	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.95e-05	0.000491	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000481	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000478	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000474	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000472	CcSEcCtD
Sitagliptin—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.00047	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000467	CcSEcCtD
Sitagliptin—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000462	CcSEcCtD
Sitagliptin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000458	CcSEcCtD
Sitagliptin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000452	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000449	CcSEcCtD
Sitagliptin—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000448	CcSEcCtD
Sitagliptin—Constipation—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000445	CcSEcCtD
Sitagliptin—Pain—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000445	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.000438	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000435	CcSEcCtD
Sitagliptin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000428	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000428	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000425	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.72e-05	0.000423	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000418	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000415	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000415	CcSEcCtD
Sitagliptin—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000413	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000411	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000411	CcSEcCtD
Sitagliptin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000411	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000396	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000393	CcSEcCtD
Sitagliptin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.98e-05	0.000383	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000382	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.00038	CcSEcCtD
Sitagliptin—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000373	CcSEcCtD
Sitagliptin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000356	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.46e-05	0.000354	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000345	CcSEcCtD
Sitagliptin—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.27e-05	0.000344	CcSEcCtD
Sitagliptin—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000331	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000329	CcSEcCtD
Sitagliptin—Rash—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000328	CcSEcCtD
Sitagliptin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000328	CcSEcCtD
Sitagliptin—Headache—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000326	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.8e-05	0.000318	CcSEcCtD
Sitagliptin—Nausea—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000309	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000306	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000303	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000303	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000301	CcSEcCtD
Sitagliptin—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000286	CcSEcCtD
